| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.59B | 22.21B | 19.57B | 20.00B | 16.01B | 13.32B |
| Gross Profit | 10.15B | 9.97B | 9.18B | 8.45B | 6.84B | 5.79B |
| EBITDA | 3.29B | 3.22B | 2.70B | 2.31B | 657.80M | 238.40M |
| Net Income | 1.87B | 1.96B | 1.55B | 1.21B | 958.45M | -130.58M |
Balance Sheet | ||||||
| Total Assets | 13.08B | 14.24B | 14.75B | 12.94B | 11.46B | 8.79B |
| Cash, Cash Equivalents and Short-Term Investments | 6.31B | 6.71B | 7.51B | 4.99B | 3.16B | 3.37B |
| Total Debt | 2.74B | 3.11B | 4.15B | 3.14B | 3.53B | 1.89B |
| Total Liabilities | 6.01B | 6.59B | 7.93B | 7.25B | 7.23B | 4.21B |
| Stockholders Equity | 7.00B | 7.60B | 6.79B | 5.69B | 4.23B | 4.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.37B | 2.09B | 987.77M | -829.02M | -868.05M |
| Operating Cash Flow | 0.00 | 1.74B | 2.53B | 1.67B | -94.53M | -200.62M |
| Investing Cash Flow | 0.00 | -439.28M | -465.00M | -12.77M | -406.05M | -703.41M |
| Financing Cash Flow | 0.00 | -2.09B | 413.77M | 135.24M | 276.73M | 722.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥29.89B | 16.05 | ― | 2.45% | 19.04% | 30.67% | |
74 Outperform | ¥23.05B | 16.06 | ― | 0.73% | 17.86% | 21.52% | |
71 Outperform | ¥21.84B | 11.39 | ― | 1.70% | 22.25% | 31.88% | |
69 Neutral | ¥27.76B | 9.67 | ― | 1.21% | 7.21% | 0.30% | |
68 Neutral | ¥26.83B | 11.13 | ― | 4.36% | 12.32% | 10.42% | |
65 Neutral | ¥30.51B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |